Completed NA INTERVENTIONAL 2-arm NCT00355810

Probiotics for Irritable Bowel Syndrome

Lactobacillus Plantarum MF 1298 vs Placebo for Irritable Bowel Syndrome.

Sponsor: Gilde

Conditions Functional Gastrointestinal Disorders Irritable Bowel Syndrome

Interventions Lactobacillus plantarum MF1298 followed by placebo placebo followed by Lactobacillus plantarum MF 1298

Updated 7 times since 2017 Last updated: Jul 18, 2016 Started: Jan 31, 2006 Primary completion: Apr 30, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Functional Gastrointestinal Disorders and Irritable Bowel Syndrome, this trial is completed. The trial is conducted by Gilde and has accumulated 7 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Mar 2019 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Mar 2019 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gilde
Norwegian Food Research
Norwegian Foundation for Health and Rehabilitation
Norwegian University of Science and Technology
Sykehuset Innlandet HF

Data source: Norwegian University of Science and Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gjøvik, Norway